Annual EBITDA:
-$120.46M+$209.88M(+63.53%)Summary
- As of today, PTCT annual EBITDA is -$120.46 million, with the most recent change of +$209.88 million (+63.53%) on December 31, 2024.
- During the last 3 years, PTCT annual EBITDA has risen by +$247.72 million (+67.28%).
- PTCT annual EBITDA is now -460.09% below its all-time high of $33.45 million, reached on December 31, 2011.
Performance
PTCT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$14.60M+$41.87M(+153.52%)Summary
- As of today, PTCT quarterly EBITDA is $14.60 million, with the most recent change of +$41.87 million (+153.52%) on September 30, 2025.
- Over the past year, PTCT quarterly EBITDA has increased by +$60.08 million (+132.10%).
- PTCT quarterly EBITDA is now -98.51% below its all-time high of $976.72 million, reached on March 31, 2025.
Performance
PTCT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$954.94M+$60.08M(+6.71%)Summary
- As of today, PTCT TTM EBITDA is $954.94 million, with the most recent change of +$60.08 million (+6.71%) on September 30, 2025.
- Over the past year, PTCT TTM EBITDA has increased by +$933.09 million (+4270.83%).
- PTCT TTM EBITDA is now at all-time high.
Performance
PTCT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PTCT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +63.5% | +132.1% | +4270.8% |
| 3Y3 Years | +67.3% | +140.8% | +470.2% |
| 5Y5 Years | +38.3% | +144.0% | +395.2% |
PTCT EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +67.3% | -98.5% | +112.0% | at high | +407.8% |
| 5Y | 5-Year | at high | +67.3% | -98.5% | +112.0% | at high | +373.3% |
| All-Time | All-Time | -460.1% | +67.3% | -98.5% | +109.3% | at high | +373.3% |
PTCT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $14.60M(+153.5%) | $954.94M(+6.7%) |
| Jun 2025 | - | -$27.27M(-102.8%) | $894.86M(-0.1%) |
| Mar 2025 | - | $976.72M(>+9900.0%) | $895.80M(+1360.2%) |
| Dec 2024 | -$120.46M(+63.5%) | -$9.11M(+80.0%) | -$71.08M(-425.4%) |
| Sep 2024 | - | -$45.48M(-72.7%) | $21.85M(+43.7%) |
| Jun 2024 | - | -$26.34M(-367.6%) | $15.20M(+159.9%) |
| Mar 2024 | - | $9.84M(-88.3%) | -$25.37M(+75.8%) |
| Dec 2023 | -$330.34M(+10.2%) | $83.83M(+260.8%) | -$104.66M(+66.3%) |
| Sep 2023 | - | -$52.13M(+22.1%) | -$310.27M(-5.6%) |
| Jun 2023 | - | -$66.91M(+3.7%) | -$293.95M(+3.0%) |
| Mar 2023 | - | -$69.45M(+43.0%) | -$303.04M(+0.2%) |
| Dec 2022 | -$367.78M(+0.1%) | -$121.79M(-240.2%) | -$303.59M(-17.7%) |
| Sep 2022 | - | -$35.80M(+52.9%) | -$257.94M(+9.8%) |
| Jun 2022 | - | -$76.00M(-8.6%) | -$285.82M(+1.7%) |
| Mar 2022 | - | -$70.00M(+8.1%) | -$290.79M(+4.2%) |
| Dec 2021 | -$368.18M(-21.5%) | -$76.15M(-19.6%) | -$303.43M(-0.1%) |
| Sep 2021 | - | -$63.68M(+21.3%) | -$303.16M(-11.2%) |
| Jun 2021 | - | -$80.96M(+2.0%) | -$272.68M(+22.0%) |
| Mar 2021 | - | -$82.64M(-8.9%) | -$349.42M(-0.3%) |
| Dec 2020 | -$303.09M(-55.2%) | -$75.88M(-128.6%) | -$348.30M(-7.7%) |
| Sep 2020 | - | -$33.19M(+79.0%) | -$323.53M(+2.9%) |
| Jun 2020 | - | -$157.70M(-93.4%) | -$333.16M(-65.6%) |
| Mar 2020 | - | -$81.53M(-59.5%) | -$201.22M(-25.3%) |
| Dec 2019 | -$195.25M(-118.2%) | -$51.11M(-19.3%) | -$160.62M(-8.6%) |
| Sep 2019 | - | -$42.83M(-66.3%) | -$147.88M(-1.1%) |
| Jun 2019 | - | -$25.76M(+37.1%) | -$146.20M(-22.0%) |
| Mar 2019 | - | -$40.92M(-6.7%) | -$119.80M(-33.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$89.47M(-92.0%) | -$38.37M(+6.8%) | -$89.60M(-124.9%) |
| Sep 2018 | - | -$41.16M(-6461.2%) | -$39.84M(-106.6%) |
| Jun 2018 | - | $647.00K(+106.0%) | -$19.28M(+39.0%) |
| Mar 2018 | - | -$10.72M(-194.1%) | -$31.59M(+32.2%) |
| Dec 2017 | -$46.61M(+63.8%) | $11.39M(+155.3%) | -$46.61M(+43.3%) |
| Sep 2017 | - | -$20.60M(-76.6%) | -$82.18M(+11.5%) |
| Jun 2017 | - | -$11.66M(+54.7%) | -$92.83M(+20.2%) |
| Mar 2017 | - | -$25.74M(-6.5%) | -$116.37M(+7.9%) |
| Dec 2016 | -$128.77M(+21.6%) | -$24.18M(+22.6%) | -$126.32M(+15.5%) |
| Sep 2016 | - | -$31.25M(+11.2%) | -$149.54M(+6.4%) |
| Jun 2016 | - | -$35.20M(+1.4%) | -$159.77M(+1.7%) |
| Mar 2016 | - | -$35.69M(+24.7%) | -$162.51M(+1.1%) |
| Dec 2015 | -$164.25M(-69.0%) | -$47.40M(-14.3%) | -$164.25M(-10.6%) |
| Sep 2015 | - | -$41.47M(-9.3%) | -$148.54M(-10.7%) |
| Jun 2015 | - | -$37.94M(-1.3%) | -$134.12M(-10.9%) |
| Mar 2015 | - | -$37.44M(-18.1%) | -$120.99M(-24.5%) |
| Dec 2014 | -$97.18M(-126.0%) | -$31.69M(-17.1%) | -$97.18M(-17.1%) |
| Sep 2014 | - | -$27.06M(-9.1%) | -$83.00M(-39.2%) |
| Jun 2014 | - | -$24.81M(-82.1%) | -$59.63M(-22.5%) |
| Mar 2014 | - | -$13.62M(+22.2%) | -$48.67M(-13.2%) |
| Dec 2013 | -$43.00M(-78.4%) | -$17.51M(-374.8%) | -$43.00M(-68.7%) |
| Sep 2013 | - | -$3.69M(+73.4%) | -$25.49M(-16.9%) |
| Jun 2013 | - | -$13.86M(-74.2%) | -$21.81M(-174.2%) |
| Mar 2013 | - | -$7.95M(-27.8%) | -$7.95M(-27.8%) |
| Dec 2012 | -$24.10M(-172.1%) | - | - |
| Mar 2012 | - | -$6.22M | -$6.22M |
| Dec 2011 | $33.45M | - | - |
FAQ
- What is PTC Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. annual EBITDA year-on-year change?
- What is PTC Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is PTC Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. TTM EBITDA year-on-year change?
What is PTC Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of PTCT is -$120.46M
What is the all-time high annual EBITDA for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high annual EBITDA is $33.45M
What is PTC Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, PTCT annual EBITDA has changed by +$209.88M (+63.53%)
What is PTC Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of PTCT is $14.60M
What is the all-time high quarterly EBITDA for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high quarterly EBITDA is $976.72M
What is PTC Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, PTCT quarterly EBITDA has changed by +$60.08M (+132.10%)
What is PTC Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of PTCT is $954.94M
What is the all-time high TTM EBITDA for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high TTM EBITDA is $954.94M
What is PTC Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, PTCT TTM EBITDA has changed by +$933.09M (+4270.83%)